Osmosis Investment Management UK Ltd purchased a new position in Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) during the 2nd quarter, HoldingsChannel reports. The firm purchased 10,576 shares of the technology company’s stock, valued at approximately $3,856,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CLS. Legacy Wealth Managment LLC ID grew its stake in Celestica by 14.4% during the 1st quarter. Legacy Wealth Managment LLC ID now owns 223 shares of the technology company’s stock worth $63,000 after buying an additional 28 shares during the last quarter. Capital Planning LLC lifted its stake in Celestica by 3.2% in the first quarter. Capital Planning LLC now owns 1,025 shares of the technology company’s stock valued at $289,000 after buying an additional 32 shares during the last quarter. PCB Capital LLC lifted its stake in Celestica by 3.5% in the first quarter. PCB Capital LLC now owns 995 shares of the technology company’s stock valued at $280,000 after buying an additional 34 shares during the last quarter. Avantax Planning Partners Inc. boosted its holdings in shares of Celestica by 2.7% during the fourth quarter. Avantax Planning Partners Inc. now owns 1,528 shares of the technology company’s stock valued at $452,000 after acquiring an additional 40 shares during the period. Finally, Park Square Financial Group LLC boosted its holdings in shares of Celestica by 36.3% during the fourth quarter. Park Square Financial Group LLC now owns 154 shares of the technology company’s stock valued at $46,000 after acquiring an additional 41 shares during the period. Institutional investors and hedge funds own 67.38% of the company’s stock.
Celestica Price Performance
Shares of CLS opened at $296.03 on Monday. The firm has a market capitalization of $34.04 billion, a price-to-earnings ratio of 30.77 and a beta of 2.06. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23. Celestica, Inc. has a one year low of $179.01 and a one year high of $474.02. The stock’s fifty day moving average is $341.15 and its 200-day moving average is $335.51.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the stock. UBS Group raised shares of Celestica from a “neutral” rating to a “buy” rating and set a $430.00 price objective on the stock in a report on Monday. Bank of America reissued a “buy” rating on shares of Celestica in a research note on Wednesday, July 29th. Weiss Ratings cut shares of Celestica from a “buy (b)” rating to a “buy (b-)” rating in a research report on Thursday, August 13th. Scotiabank initiated coverage on shares of Celestica in a research note on Tuesday, August 11th. They issued a “sector outperform” rating and a $500.00 price target on the stock. Finally, Citigroup lifted their price target on Celestica from $338.00 to $415.00 and gave the company a “buy” rating in a report on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Celestica has a consensus rating of “Buy” and an average price target of $439.81.
Get Our Latest Analysis on CLS
Insider Activity
In other Celestica news, CFO Mandeep Chawla sold 17,000 shares of the firm’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the transaction, the chief financial officer owned 82,444 shares of the company’s stock, valued at approximately $32,948,744.60. This trade represents a 17.10% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Robert Mionis sold 98,453 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total transaction of $36,328,172.47. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 356,553 shares of company stock worth $135,238,444. 1.10% of the stock is owned by corporate insiders.
Celestica Profile
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Recommended Stories
- Five stocks we like better than Celestica
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS).
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
